Govt to bear cost of 30 crore vaccinations from priority group, says Dr Vinod Paul

▴ Govt to bear cost of 30 crore vaccinations from priority group, says Dr Vinod Paul
30 crore citizens from the priority group are eligible

Niti Aayog member and the national Covid-19 task force head, Dr Vinod Paul said on Friday that the government will cover the vaccination cost of 30 crore people from the priority group, not the whole population.

In the next six to eight months, people from the priority group such as frontline workers and people with comorbidities will be targeted in phase 1 of the vaccination drive. Dr Paul said the Covid task force wants to minimise deaths related to coronavirus, hence, "we chose higher risk groups".

"India will pitch for vaccines for 300 million individuals. Preparedness for inoculating other groups prioritised by the government is also in its advanced stages," he said in an interview with CNBC-TV18.

The Covid task force head also added 31 coronavirus vaccine hubs have been set up to supply vaccines to 29,000 vaccination points. He said the priority group will have 300 million individuals and the government will bear the cost of 30 crore from it.

Dr Paul said the ultimate goal is to stop the spread of the coronavirus infection.

Story Courtesy ; www.indiatoday.com 

Tags : #DrVinodPaul #CovidTaskForce #NITIAyog #Prioritygroup

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024